On Wednesday, shares of Moderna (NASDAQ:MRNA) are up about 14% in pre-market trading after Merck (NYSE:MRK) exercised its option to develop and commercialise a personalised...
The Food and Drug Administration (FDA) is thinking to approve a second Covid-19 vaccine booster for people above 50 years of age amid concerns about...
Moderna has requested the US Food and Drug Administration (FDA) for emergency use authorisation (EUA) on the fourth dose of its Covid-19 vaccine for adults...
The CDC panel advised the US government that Americans should be given Pfizer or Moderna vaccines against Covid-19 over the Johnson & Johnson (J&J) vaccine...
US citizens can now choose a different company’s vaccine for that next booster shot, federal health officials said. People who got the Pfizer vaccine are...
Zydus Cadila‘s Covid-19 vaccine ZyCoV-D is getting a nod for emergency use in India by this week. Union Health Minister Mansukh Mandaviya in the Rajya...
Indian drugmaker Zydus Cadila has applied to the Central Drugs Standard Control Organisation (CDSCO) for emergency use approval of its Covid-19 vaccine, which showed a...
Cipla, a multinational pharmaceutical company headquartered in Mumbai, on Tuesday received approval from the Drugs Controller General of India (DCGI) to import Moderna’s coronavirus vaccine...
A new study conducted by a group of scientists has found that Moderna’s Covid-19 vaccine produces strong neutralizing antibody responses to the virus in baby...